aristolochic acid i has been researched along with Hospital-Acquired Condition in 3 studies
aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Tomlinson, T | 1 |
Fernandes, A | 1 |
Grollman, AP | 2 |
Odell, AF | 1 |
Odell, LR | 1 |
Askham, JM | 1 |
Alogheli, H | 1 |
Ponnambalam, S | 1 |
Hollstein, M | 1 |
1 review available for aristolochic acid i and Hospital-Acquired Condition
Article | Year |
---|---|
Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.
Topics: Aristolochic Acids; Balkan Nephropathy; DNA Adducts; Humans; Iatrogenic Disease; Kidney Cortex; Kidn | 2013 |
2 other studies available for aristolochic acid i and Hospital-Acquired Condition
Article | Year |
---|---|
Topics: Aristolochia; Aristolochic Acids; Carcinogens; Gout; Gout Suppressants; History; Humans; Iatrogenic | 2020 |
A novel p53 mutant found in iatrogenic urothelial cancers is dysfunctional and can be rescued by a second-site global suppressor mutation.
Topics: Amino Acid Substitution; Animals; Aristolochic Acids; Biomarkers, Tumor; Cell Line, Transformed; Hum | 2013 |